Bausch+Lomb Investor Conference Presentation Deck
2022 Bausch+Lomb Separation Progress¹
Filed Registration Statement and Preliminary Prospectus
for Proposed Initial Public Offering
Launched Roadshow and IPO
BLCO First Day of Trading (May 6, 2022)
on NYSE and TSX
BLCO is Not a Guarantor of BHC Debt
BHC Announced the Unrestricting of BLCO Under BHC
Debt Covenants (Nov. 29, 2022)
BAUSCH + LOMB
Stanley
+Lomb on
lates
BAUSCH
N
+LOMB
punem votate to these sezamastamise
Sacal11th Comme
better by meens die st
may be cale Morgan
&
e Apes Dup for vinks 2 Fr NY NY S
"We continue to believe that the separation of Bausch and Lomb makes strategic sense and we will thoughtfully
evaluate all factors related to the B&L separation." - Bausch Health Companies 3Q22 Earnings Call
1. The completion of the B+L Separation is subject to a number of factors including receipt of applicable shareholder and other necessary approvals, market conditions and achievement of targeted debt leverage ratios. See Slide 1 for further information regarding forward-looking statements.
9View entire presentation